iodixanol has been researched along with Myocarditis in 2 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, SR | 1 |
| Shah, AS | 1 |
| Richards, J | 1 |
| Lang, NN | 1 |
| Barnes, G | 1 |
| Joshi, N | 1 |
| MacGillivray, T | 1 |
| McKillop, G | 1 |
| Mirsadraee, S | 1 |
| Payne, J | 1 |
| Fox, KA | 1 |
| Henriksen, P | 1 |
| Newby, DE | 1 |
| Semple, SI | 1 |
| Sosnovik, DE | 1 |
| Nahrendorf, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pathogenesis of Acute Stress Induced (Tako-tsubo) Cardiomyopathy: Energy Shut-Down or Intense Inflammation? The TERRIFIC Study[NCT02897739] | 77 participants (Actual) | Observational [Patient Registry] | 2015-08-31 | Completed | |||
| Ferumoxytol for Magnetic Resonance Imaging of Myocardial Infarction[NCT01323296] | 15 participants (Actual) | Interventional | 2010-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for iodixanol and Myocarditis
| Article | Year |
|---|---|
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Dextrans; Female; Humans; Infusio | 2012 |
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Dextrans; Female; Humans; Infusio | 2012 |
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Dextrans; Female; Humans; Infusio | 2012 |
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Dextrans; Female; Humans; Infusio | 2012 |
Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction.
Topics: Dextrans; Female; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Myocardial Infa | 2012 |